Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial

BJU International

Volumn 106, Issue 4, 2010, Pages 472-477

  Malmi, Hanna ^a   Ruutu, Mirja ^a   Määttänen, Liisa ^b   Stenman, Ulf Hakan ^a   Juusela, Harri ^a   Tammela, Teuvo L J ^c   Auvinen, Anssi ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

mass screening; patient withdrawal; prostatic neoplasms; quality of life; randomized controlled trial

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL RESEARCH; DIAGNOSTIC TEST; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL HEALTH; PERCEPTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; FINLAND; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PROSTATIC NEOPLASMS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

AGED; ATTITUDE TO HEALTH; EARLY DETECTION OF CANCER; FINLAND; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERCEPTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77955065127     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09165.x     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108
2. Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate-cancer mortality in a randomised European study. N Engl J Med 2009 360 : 1320 1328
3. Andriole GL, Crawford ED, Grubb RL et al. Mortality Results from a randomized prostate cancer screening trial. N Engl J Med 2009 360 : 1310 1319
4. Auvinen A, Alexander FE, de Koning HJ, Miller AB. Should we start population screening for prostate cancer? Int J Cancer 2002 97 : 377 378
5. de Koning HJ, Auvinen A, Berenguer Sanchez A et al. Large-scale randomized prostate cancer screening trials. Program performances in the European randomized screening for prostate cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002 97 : 237 244
6. Miller AB, Madalinska JB, Church T et al. Health-related quality of life and cost-effectiveness studies in the European randomized study of screening for prostate cancer and the US prostate, lung, colon and ovary trial. Eur J Cancer 2001 37 : 2154 2160
7. Essink-Bot M-L, de Koning HJ, Nijs HGT, Kirkels W, Van der Maas P, Schröder FH. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998 90 : 925 931
8. Nijs HGT, Essink-Bot M-L, de Koning HJ, Kirkels W, Schröder FH. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000 22 : 312 316
9. Finne P, Stenman U-H, Määttänen L et al. The Finnish trial of prostate cancer screening: where are we now? BJU Int 2003 92 : 22 6
10. Aalto A-M, Aro AM, Teperi J. RAND-36 As A Measure of Health-Related Quality of Life: Reliability, Construct Validity and Reference Values in the Finnish General Population.
11. Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-95; Recent increase in cervical cancer incidence. Int J Cancer 1999 83 : 59 65
12. Prättälä R, Paalanen L eds. Health Behaviour and Its Socio-demographic Differences in Finland. Health 2000 Survey. Publications of the National Public Health Institute B2/2007. Helsinki: National Public Health Institute; 2007. Available at: http://www.ktl.fi/attachments/suomi/julkaisut/ julkaisusarja-b/2007/2007b02.pdf. Accessed February 2010
13. Helakorpi S, Uutela A et al. Health Behaviour and Health among Finnish Adult Population. Year 2000 Report.
14. Moinpour CM, Lovato LC, Thompson IM et al. Profile of men randomized to the prostate cancer prevention trial: Baseline health-related quality of life, urinary and sexual functioning, and health behaviours. J Clin Oncol 2000 18 : 1942 1953
15. Rijnsburger AJ, Essink-Bot M-L, Van Dooren S et al. Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 2004 91 : 69 76
16. Becker MH. The health belief model and personal health behavior. Health Educ Monogr 1974 2 : 324 473
17. Eaker S, Adami H-O, Sparén P. Attitudes to screening for cervical cancer: a population-based study in Sweden. Cancer Causes Control 2001 12 : 519 528 (Pubitemid 32735124)
18. Eaker S, Adami H-O, Granath F, Wilander E, Sparén P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004 13 : 346 354
19. Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. J Med Screen 1999 6 : 82 8
20. Evans R, Edwards A, Brett J et al. Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Patient Educ Councel 2005 58 : 13 26
21. Watson E, Hewitson P, Brett J et al. Informed Decision Making and Prostate Spesific Antigen (PSA) Testing for Prostate Cancer: A Randomized Controlled Trial Exploring the Impact of A Brief Patient Decision Aid on Men's Knowledge, Attitudes and Intention to Be Tested. Patient Educ Councel 2006 63 : 367 379